Welcome to Markets Desk, your midday read on what's moving and why.
Clearway Energy delivered a strong third quarter, posting net income of one hundred twenty three million dollars alongside adjusted EBITDA of four hundred thirty five million. Cash available for distribution came in at one hundred seventy three million, and management reaffirmed full-year guidance, signaling confidence in the renewable energy operator's underlying asset performance.
Shifting to biotech, Structure Therapeutics reported cash and short-term investments of one point two billion dollars as of September thirtieth, two thousand twenty six, down modestly from one point three billion the prior quarter. The company says its current reserves are sufficient to fund projected operations, keeping its clinical runway intact without immediate need for additional capital raises.
And on the patent holding side, Network-One Technologies posted no revenue for the third quarter of two thousand twenty six, with a net loss widening sharply to two million three hundred thirty three thousand dollars, or ten cents per diluted share, compared to a much smaller loss in the same period a year prior. The absence of licensing income remains the defining pressure on this balance sheet.
That's the tape. Markets Desk, signing off the floor.
